Chronic Kidney Disease (CKD)
Chronic kidney disease occurs when abnormalities of kidney structure or function persist over time. Early CKD may have few or no symptoms, making appropriate laboratory testing important for detection and monitoring.
Kidney disease may progress silently — monitoring eGFR and urine ACR can help identify kidney dysfunction or kidney damage at an earlier stage, before symptoms develop.
At National Path Lab (NPL), comprehensive kidney function and urine testing is available to support the detection, staging, and monitoring of chronic kidney disease.
- Tests available
- 7
- Tests available
Tests Available at NPL
COMPLETE BLOOD COUNT
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 500
RENAL FUNCTION TEST
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 1000
PARATHYROID HORMONE; PTH INTACT
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 3000
CALCIUM TOTAL, SERUM
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 400
GFR (GLOMERULAR FILTRATION RATE), ESTIMATED
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 600
MICROALBUMIN CREATININE RATIO; ACR
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 1200
PHOSPHORUS, SERUM
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 500
About Chronic Kidney Disease (CKD)
Causes & Risk Factors
CKD develops from a variety of underlying conditions and risk factors, often progressing gradually over years:
• Diabetes — one of the leading causes of CKD worldwide.
• Hypertension — both a cause and a consequence of kidney disease, creating a cycle that can accelerate progression.
• Cardiovascular disease — shares risk factors with, and is closely linked to, kidney disease.
• Family history of kidney disease.
• Recurrent urinary abnormalities or kidney stones.
• Long-term use of certain medications that may affect kidney function.
Symptoms & When to Test
Early CKD is often asymptomatic, which is precisely why proactive testing in at-risk individuals — rather than waiting for symptoms — is emphasized for early detection.
• Often no symptoms in early stages
• Fatigue, in more advanced disease
• Swelling in the legs or around the eyes, as disease progresses
• Changes in urination patterns
• Symptoms may not appear until significant kidney function has already been lost
When Should You Consider Testing?
Testing may be considered in individuals with diabetes, hypertension, cardiovascular disease, family history of kidney disease, recurrent urinary abnormalities, persistent proteinuria or albuminuria, abnormal creatinine or eGFR, recurrent kidney stones, or long-term use of medications that may affect kidney function.
Why Tests Are Combined
Serum creatinine and eGFR together estimate kidney filtration capacity, while urine ACR detects albumin loss — these are complementary rather than redundant, since a person can have reduced filtration with minimal albumin loss, or significant albumin loss with relatively preserved filtration, and CKD can present with either or both patterns.
Urinalysis, urea, and electrolytes provide broader information about overall urinary and metabolic status, while calcium/phosphate and PTH become increasingly relevant as CKD progresses, since mineral and bone disorders are a recognized complication of more advanced disease.
CBC is included because anemia is a common complication of CKD (related to reduced kidney production of erythropoietin), making it a relevant marker to monitor alongside direct kidney function tests as part of comprehensive CKD assessment.
Tests Available at NPL
Test Code | Test | Clinical Relevance |
B0061
| RENAL FUNCTION TEST | Measures a waste product cleared by the kidneys; used to assess kidney function. |
B0035
| eGFR (Estimated Glomerular Filtration Rate) | Estimates kidney filtration capacity using serum creatinine and relevant patient factors. |
B0052
| Urine Albumin-to-Creatinine Ratio (ACR) | Detects and quantifies albumin loss in urine; important for identifying kidney damage. |
C0014
| Urinalysis | Evaluates urine for blood, protein, glucose, cells, and other abnormalities. |
B0015/B0056
| Calcium / Phosphate | Important in the evaluation of mineral and bone abnormalities associated with advanced CKD. |
H0012
| CBC | Helps assess anemia and other hematological abnormalities associated with kidney disease. |
I0068
| PTH (Parathyroid Hormone) | May be assessed in patients with CKD-related mineral and bone disorders. |
Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.
Home Sample Collection
NPL offers convenient home sample collection for Chronic Kidney Disease (CKD) blood tests, so you don't need to visit a lab in person.
→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.
→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.
→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2012laboratory for processing.
→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.
When to See a Doctor
• Known diabetes, hypertension, or cardiovascular disease — regular kidney screening is recommended
• Family history of kidney disease
• Recurrent urinary abnormalities or kidney stones
• Abnormal creatinine or eGFR on prior testing
• Unexplained swelling in the legs or around the eyes
Medical Disclaimer Laboratory tests support the detection, staging, and monitoring of chronic kidney disease but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional. |
